Selma Silagi

1.2k total citations
34 papers, 1.0k citations indexed

About

Selma Silagi is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Selma Silagi has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Immunology and 9 papers in Genetics. Recurrent topics in Selma Silagi's work include Immunotherapy and Immune Responses (9 papers), RNA Interference and Gene Delivery (8 papers) and Virus-based gene therapy research (7 papers). Selma Silagi is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), RNA Interference and Gene Delivery (8 papers) and Virus-based gene therapy research (7 papers). Selma Silagi collaborates with scholars based in United States. Selma Silagi's co-authors include Sarah A. Bruce, Elizabeth W. Newcomb, Jean R. Wrathall, Samuel C. Silverstein, Lloyd H. Graf, Delia Beju, George Acs, Edward Essner, Judith K. Christman and Constance Oliver and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Cell Biology.

In The Last Decade

Selma Silagi

34 papers receiving 875 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Selma Silagi United States 18 541 242 225 173 150 34 1.0k
P T Mora United States 15 449 0.8× 118 0.5× 265 1.2× 205 1.2× 187 1.2× 33 802
Terence Cartwright United Kingdom 15 552 1.0× 116 0.5× 172 0.8× 107 0.6× 57 0.4× 41 1.1k
G W Bazill United Kingdom 17 481 0.9× 190 0.8× 92 0.4× 150 0.9× 82 0.5× 23 860
E. Durban United States 17 700 1.3× 166 0.7× 233 1.0× 317 1.8× 159 1.1× 38 1.2k
Adolfo Soffientini Italy 18 551 1.0× 241 1.0× 196 0.9× 92 0.5× 64 0.4× 30 1.1k
James E. Strickland United States 17 674 1.2× 190 0.8× 301 1.3× 207 1.2× 249 1.7× 47 1.2k
Guang‐Jer Wu United States 23 865 1.6× 109 0.5× 262 1.2× 206 1.2× 105 0.7× 48 1.3k
Vivian W. McFarland United States 15 488 0.9× 152 0.6× 208 0.9× 192 1.1× 72 0.5× 20 772
Dyfed L. Evans United Kingdom 10 707 1.3× 208 0.9× 252 1.1× 100 0.6× 143 1.0× 10 1.3k
Karl HOCHSTRASSER Germany 20 764 1.4× 93 0.4× 240 1.1× 80 0.5× 195 1.3× 59 1.3k

Countries citing papers authored by Selma Silagi

Since Specialization
Citations

This map shows the geographic impact of Selma Silagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Selma Silagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Selma Silagi more than expected).

Fields of papers citing papers by Selma Silagi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Selma Silagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Selma Silagi. The network helps show where Selma Silagi may publish in the future.

Co-authorship network of co-authors of Selma Silagi

This figure shows the co-authorship network connecting the top 25 collaborators of Selma Silagi. A scholar is included among the top collaborators of Selma Silagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Selma Silagi. Selma Silagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Silagi, Selma, et al.. (1989). In vivo requirement for asialo GM1 and Thy1 positive leukocytes for antitumor effect of rIL-2 +/- rIFN-gamma.. PubMed. 8(6). 1265–9. 4 indexed citations
2.
Silagi, Selma, et al.. (1988). Eradication of mouse melanoma by combined treatment with recombinant human interleukin 2 and recombinant murine interferon‐gamma. International Journal of Cancer. 41(2). 315–322. 30 indexed citations
3.
Pinter, Abraham, et al.. (1986). Ecotropic murine leukemia virus-induced fusion of murine cells. Journal of Virology. 57(3). 1048–1054. 55 indexed citations
4.
Silagi, Selma, et al.. (1986). Successful immunotherapy of mouse melanoma and sarcoma with recombinant interleukin-2 and cyclophosphamide.. PubMed. 5(5). 411–22. 23 indexed citations
5.
Albino, Anthony P., et al.. (1985). DNA-Mediated Transfer of Human Melanoma Cell Surface Glycoprotein gp130: Identification of Transfectants by Erythrocyte Rosetting. Molecular and Cellular Biology. 5(4). 692–697. 5 indexed citations
6.
Calvelli, Theresa, Victoria H. Freedman, Samuel C. Silverstein, & Selma Silagi. (1982). Leukocyte subpopulations elicited by a nontumorigenic variant of B16 melanoma: their role in direct rejection of the melanoma and in prevention of tumorigenesis in Winn assays.. The Journal of Experimental Medicine. 156(6). 1723–1738. 7 indexed citations
7.
Calvelli, Theresa, et al.. (1981). Immunization of syngeneic mice against malignant melanoma with subcellular membrane fractions of a bromodeoxyuridine-grown variant. Cancer Immunology Immunotherapy. 12(1). 1 indexed citations
8.
Freedman, Victoria H., Theresa Calvelli, Selma Silagi, & S C Silverstein. (1980). Macrophages elicited with heat-killed bacillus Calomette-Guérin protect C57BL/6J mice against a syngeneic melanoma.. The Journal of Experimental Medicine. 152(3). 657–673. 30 indexed citations
9.
Levy, J A, et al.. (1979). Recovery of Three Distinct Biologically Active Type C Viruses from Cloned C57Bl/6 Melanoma Cells. Journal of General Virology. 43(2). 283–288. 4 indexed citations
10.
Kyner, David, Judith K. Christman, George Acs, et al.. (1978). Co‐cultivation of tumorigenic mouse melanoma cells with cells of a non‐tumorigenic subclone inhibits plasminogen activator expression by the melanoma cells. Journal of Cellular Physiology. 95(2). 159–167. 13 indexed citations
11.
Newcomb, Elizabeth W., Samuel C. Silverstein, & Selma Silagi. (1978). Malignant mouse melanoma cells do not form tumors when mixed with cells of a non‐malignant subclone: Relationships between plasminogen activator expression by the tumor cells and the host's immune response. Journal of Cellular Physiology. 95(2). 169–177. 42 indexed citations
12.
Silagi, Selma, et al.. (1977). Comparative effects on growth and tumorigenicity of mouse melanoma cells by thymidine and its analogs, 5-ethyl- and 5-bromodeoxyuridine.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(9). 3367–73. 9 indexed citations
13.
14.
Christman, Judith K., Selma Silagi, Elizabeth W. Newcomb, Samuel C. Silverstein, & George Acs. (1975). Correlated suppression by 5-bromodeoxyuridine of tumorigenicity and plasminogen activator in mouse melanoma cells.. Proceedings of the National Academy of Sciences. 72(1). 47–50. 49 indexed citations
15.
Wrathall, Jean R., Elizabeth W. Newcomb, Robert F. Balint, L. Zeitz, & Selma Silagi. (1975). Suppression of melanoma cell tyrosinase activity and tumorigenicity after incorporation of bromouracil for one or two cell divisions. Journal of Cellular Physiology. 86(S2). 581–592. 12 indexed citations
16.
Silagi, Selma, et al.. (1972). Tumorigenicity, Immunogenicity, and Virus Production in Mouse Melanoma Cells Treated with 5-Bromodeoxyuridine. Proceedings of the National Academy of Sciences. 69(11). 3443–3447. 60 indexed citations
17.
Silagi, Selma. (1971). Modification of malignancy by 5-bromodeoxyuridine. In Vitro Cellular & Developmental Biology - Plant. 7(2). 105–114. 28 indexed citations
18.
Silagi, Selma. (1969). CONTROL OF PIGMENT PRODUCTION IN MOUSE MELANOMA CELLS IN VITRO. The Journal of Cell Biology. 43(2). 263–274. 74 indexed citations
19.
Silagi, Selma. (1967). Hybridization of a malignant melanoma cell line with L cells in vitro.. PubMed. 27(11). 1953–60. 59 indexed citations
20.
Silagi, Selma. (1965). INTERACTIONS BETWEEN AN EXTRACHROMOSOMAL FACTOR, POKY, AND NUCLEAR GENES IN NEUROSPORA CRASSA. Genetics. 52(2). 341–347. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P T Mora Breakdown of academic impact, for papers by Terence Cartwright Breakdown of academic impact, for papers by G W Bazill Breakdown of academic impact, for papers by E. Durban Breakdown of academic impact, for papers by Adolfo Soffientini Breakdown of academic impact, for papers by James E. Strickland Breakdown of academic impact, for papers by Guang‐Jer Wu Breakdown of academic impact, for papers by Vivian W. McFarland Breakdown of academic impact, for papers by Dyfed L. Evans Breakdown of academic impact, for papers by Karl HOCHSTRASSER
Rankless by CCL
2026